Christopher Brett Primiano's most recent trade in Karyopharm Therapeutics Inc was a trade of 78,124 Common Stock done at an average price of $10.5 . Disclosure was reported to the exchange on Dec. 1, 2020.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Karyopharm Therapeutics Inc | Christopher Brett Primiano | EVP, CBO, GC & Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.45 per share. | 01 Dec 2020 | 78,124 | 82,647 (0%) | 0% | 10.5 | 816,396 | Common Stock |
| Karyopharm Therapeutics Inc | Christopher Brett Primiano | EVP, CBO, GC & Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Dec 2020 | 78,124 | 46,876 | - | - | Stock Option (right to buy) | |
| Karyopharm Therapeutics Inc | Christopher Brett Primiano | EVP, CBO, GC & Secretary | Sale of securities on an exchange or to another person at price $ 17.66 per share. | 01 Dec 2020 | 78,124 | 4,523 (0%) | 0% | 17.7 | 1,379,670 | Common Stock |
| Karyopharm Therapeutics Inc | Christopher Brett Primiano | EVP, CBO, GC & Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Dec 2020 | 58,937 | 16,842 | - | - | Stock Option (right to buy) | |
| Karyopharm Therapeutics Inc | Christopher Brett Primiano | EVP, CBO, GC & Secretary | Sale of securities on an exchange or to another person at price $ 17.35 per share. | 01 Dec 2020 | 58,937 | 4,523 (0%) | 0% | 17.4 | 1,022,557 | Common Stock |
| Karyopharm Therapeutics Inc | Christopher Brett Primiano | EVP, CBO, GC & Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.39 per share. | 01 Dec 2020 | 58,937 | 63,460 (0%) | 0% | 10.4 | 612,355 | Common Stock |
| Karyopharm Therapeutics Inc | Christopher Brett Primiano | EVP, CBO, GC & Secretary | Sale of securities on an exchange or to another person at price $ 14.92 per share. | 02 Nov 2020 | 772 | 4,523 (0%) | 0% | 14.9 | 11,518 | Common Stock |
| Karyopharm Therapeutics Inc | Christopher Brett Primiano | EVP, CBO, GC & Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Oct 2020 | 38,550 | 64,250 | - | - | Stock Option (right to buy) | |
| Karyopharm Therapeutics Inc | Christopher Brett Primiano | EVP, CBO, GC & Secretary | Sale of securities on an exchange or to another person at price $ 16.85 per share. | 13 Oct 2020 | 38,550 | 4,649 (0%) | 0% | 16.9 | 649,568 | Common Stock |
| Karyopharm Therapeutics Inc | Christopher Brett Primiano | EVP, CBO, GC & Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.21 per share. | 13 Oct 2020 | 38,550 | 43,199 (0%) | 0% | 9.2 | 355,046 | Common Stock |
| Karyopharm Therapeutics Inc | Christopher Brett Primiano | EVP, CBO, GC & Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Oct 2020 | 721 | 75,779 | - | - | Stock Option (right to buy) | |
| Karyopharm Therapeutics Inc | Christopher Brett Primiano | EVP, CBO, GC & Secretary | Sale of securities on an exchange or to another person at price $ 17.20 per share. | 13 Oct 2020 | 721 | 4,649 (0%) | 0% | 17.2 | 12,401 | Common Stock |
| Karyopharm Therapeutics Inc | Christopher Brett Primiano | EVP, CBO, GC & Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.39 per share. | 13 Oct 2020 | 721 | 5,370 (0%) | 0% | 10.4 | 7,491 | Common Stock |